Dysregulation of the Hippo signaling pathway, a key regulator of tissue growth and homeostasis, leads to the activation of the TAZ oncogene and its transcriptional target IRS1 (insulin receptor substrate 1) in BC [88,89]. This evidence concerns the gene IRS1 and breast cancer.